Newsletter Signup x
Acute myeloid leukaemia is the second most common form of childhood leukaemia, with 100 children diagnosed every year in the UK. Around a third of these young patients cannot be saved with existing treatments. Dr Mussai is taking forward a new approach to treatment that could offer new hope to children with this devastating disease.
We are grateful to the Aila Coull Foundation for providing the funding to support this project.
A new treatment approach in acute myeloid leukaemia
Dr Francis Mussai
University of Birmingham
Birmingham B15 2TT
1 April 2014
21 months
£43,393
Patient Story – Mia
Mia was diagnosed with acute lymphoblastic leukaemia just after her fourth birthday. Her dad Andy tells their story so
Read moreDrug delivery to the brain workshop
We sponsored the Children's Brain Tumour Drug Delivery Consortium (CBTDDC) workshop on drug delivery to the
Read more